AbbVie Inc.
NYSE:ABBV
$ 166.41
+ $1.75 (1.06%)
$ 166.41
+ $1.75 (1.06%)
End-of-day quote: 04/19/2024

ABBV - AbbVie Stock Prediction 2025 - 2030

11 years of reliable AbbVie stock forecast. The Wall Street analysts predict Outperform for ABBV. See at a glance whether NYSE:ABBV will rise in the future.

$121.74
Forecast 2023
$141.16
Forecast 2025
$155.37
Forecast 2030
Neutral
TopGraphs Quality Ranking
Forecast 2023
$121.74
Forecast 2025
$141.16
Forecast 2030
$155.37
TopGraphs Quality Ranking
Neutral

Company Info

P/E
0.00
Beta
0.56
Price-to-book Ratio
28.35
Market Cap
294.65B
TEV
357.18 B
Dividend
$6.27
Div Yld
3.77%
Forecast 1Y
-23.01%
Forecast 2Y
-12.83%
Analyst Price Target
$178.42
Website

AbbVie Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

AbbVie Stock Forecast 2023

$189.00

In the last five quarters, AbbVie’s Price Target has risen from $153.22 to $178.42 - a 16.45% increase. Twenty-six analysts predict that AbbVie’s share price will increase in the coming year, reaching $189.00. This would represent an increase of 5.93%.

13.57%
13.57
Last update: 04/20/2024

Highest Price Target $206.00

Average Price Target $189.00

Lowest Price Target $161.00

AbbVie Stock Predictions 2025

Stock Forecast for the Price of an AbbVie Share in Jan 2025.

In January 2025, analysts believe the stock price will be $131.01. A decrease of -21.27% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Feb 2025.

In February 2025, analysts believe the stock price will be $131.94. A decrease of -20.72% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Mar 2025.

In March 2025, analysts believe the stock price will be $132.86. A decrease of -20.16% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Apr 2025.

In April 2025, analysts believe the stock price will be $133.78. A decrease of -19.61% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in May 2025.

In May 2025, analysts believe the stock price will be $134.70. A decrease of -19.05% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Jun 2025.

In June 2025, analysts believe the stock price will be $135.63. A decrease of -18.5% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Jul 2025.

In July 2025, analysts believe the stock price will be $136.55. A decrease of -17.95% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Aug 2025.

In August 2025, analysts believe the stock price will be $137.47. A decrease of -17.39% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Sep 2025.

In September 2025, analysts believe the stock price will be $138.39. A decrease of -16.84% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Oct 2025.

In October 2025, analysts believe the stock price will be $139.31. A decrease of -16.28% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Nov 2025.

In November 2025, analysts believe the stock price will be $140.24. A decrease of -15.73% compared to the previous month's estimate.

Stock Forecast for the Price of an AbbVie Share in Dec 2025.

In December 2025, analysts believe the stock price will be $141.16. A decrease of -15.17% compared to the previous month's estimate.

AbbVie Stock Prediction 2030

Stock Prediction for the Price of One AbbVie Share in Jan 2030.

In Jan 2030 analysts predict a share price of $157.96. A decrease of -5.08% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Feb 2030.

In Feb 2030 analysts predict a share price of $157.72. A decrease of -5.22% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Mar 2030.

In Mar 2030 analysts predict a share price of $157.49. A decrease of -5.36% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Apr 2030.

In Apr 2030 analysts predict a share price of $157.25. A decrease of -5.5% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in May 2030.

In May 2030 analysts predict a share price of $157.02. A decrease of -5.64% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Jun 2030.

In Jun 2030 analysts predict a share price of $156.78. A decrease of -5.79% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Jul 2030.

In Jul 2030 analysts predict a share price of $156.55. A decrease of -5.93% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Aug 2030.

In Aug 2030 analysts predict a share price of $156.31. A decrease of -6.07% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Sep 2030.

In Sep 2030 analysts predict a share price of $156.08. A decrease of -6.21% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Oct 2030.

In Oct 2030 analysts predict a share price of $155.84. A decrease of -6.35% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Nov 2030.

In Nov 2030 analysts predict a share price of $155.61. A decrease of -6.49% compared to today's share price.

Stock Prediction for the Price of One AbbVie Share in Dec 2030.

In Dec 2030 analysts predict a share price of $155.37. A decrease of -6.63% compared to today's share price.

P/E
0.00
Beta
0.56
Price-to-book Ratio
28.35
Market Cap
294.65B
TEV
357.18 B
Dividend
$6.27
Div Yld
3.77%
Forecast 1Y
-23.01%
Forecast 2Y
-12.83%
Analyst Price Target
$178.42
Website

AbbVie Analyst Ratings Frequently Asked Questions

Who are the analysts watching AbbVie Inc.?

The following analysts have recently covered AbbVie:

Argus Research Company
Baptista Research
Barclays
Berenberg
BMO Capital Markets Equity Research
BofA Global Research
CFRA Equity Research
Citigroup Inc
Citigroup Inc. Research
Daiwa Securities Co. Ltd.
Evercore ISI
Goldman Sachs
J.P. Morgan
Marktfeld
Morgan Stanley
Morningstar Inc.
Piper Sandler Companies
Truist Securities
Vermilion Research
Wells Fargo Securities, LLC
Wolfe Research, LLC.
Capital Alpha Partners, LLC
UBS Investment Bank
BNP Paribas Exane
CFRA Policy Research
Deutsche Bank
Guggenheim Securities, LLC
HSBC
Leerink Partners LLC
Raymond James & Associates
Redburn Atlantic
S&P Global Ratings
TD Cowen
William Blair & Company L.L.C.
Itau BBA
Crisp Idea
Equisights
CGS International
(This information refers to the last 90 days.)

Who are the sell-side analysts watching AbbVie Inc.?

The following sell-side analysts have recently covered AbbVie:

Majumdar, Ishan
Hector, Luisa Caroline
Nachman, Gary Jay
Meacham, Geoffrey Christopher
Baum, Andrew Simon
Scala, Stephen Michael
Nakagiri, Narumi
Shibutani, Chris
Paraskevopoulos, Michail
Conover, Damien
Raymond, Christopher Joseph
Karnauskas, Robyn Kay Shelton
Nicoski, David P.
Bansal, Mohit
Anderson, Timothy Minton
Flynn, Terence C.
Hellweg, Jasper
Risinger, David Reed
Seigerman, Evan David
Ty Dietschi, Navann
Hardy, Sel
Shin, James John
Divan, Vamil Kishore
Kumar, Rajesh
Kaplan, David
Huynh, Trung Chuong
Clark-Gartner, Gavin
Sasson, Daniel
Gould, Carter Lewis
Smith, Rob
Ransom, John Wilson
Loss, Ira Saul
Kamadollishettaru, Amit
Talsania, Parth
Baker, Simon P.
Phipps, Matthew Christopher
Schott, Christopher Thomas
(This information refers to the last 90 days.)